LPA and obesity disorder: The autotaxin–LPA pathway could also develop an essential role in endocrine function since several studies have proposed them as potential biomarkers of hepatic steatosis in obesity [52] as well as in breast, ovarian and endometrial cancer in women [53,54,55].